Angiotensin Inhibitors And Receptor Blockers Linked To Lower Risk Of Nonmelanoma Skin Cancer
Wednesday, August 27, 2008 - 22:35
in Health & Medicine
The use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers was associated with a reduced risk of basal cell or squamous cell skin cancers in US veterans, researchers report in the Aug. 26 online issue of the Journal of the National Cancer Institute.
Read the whole article
See latest science articles from Science Daily
Latest Science Newsletter
Get the latest and most popular science news articles of the week in your Inbox!Related
- Angiotensin inhibitors and receptor blockers linked to lower risk of nonmelanoma skin cancerWed, 27 Aug 2008, 23:36:55 EDT
- Angiotensin receptor blockers are lower incidence, progression of Alzheimer's diseaseMon, 28 Jul 2008, 1:29:09 EDT
- History of nonmelanoma skin cancer is associated with increased risk for subsequent malignanciesWed, 27 Aug 2008, 23:36:58 EDT
- Raloxifene reduces risk of invasive estrogen-receptor positive breast cancerTue, 10 Jun 2008, 21:49:51 EDT
- Researchers discover scent of skin cancerWed, 20 Aug 2008, 17:14:40 EDT